Search

Search Results
Results 2151 - 2159 of 2159 for Abuse potential
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Clozaril intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Ibupane intended for persons living in Australia.
  • Drug - 31 Oct 2022
    Consumer Medicine Information (CMI) about Abilify intended for persons living in Australia.
  • Drug - 19 Jul 2022
    Consumer Medicine Information (CMI) about Abyraz intended for persons living in Australia.
  • Drug - 3 May 2022
    Consumer Medicine Information (CMI) about Aspalgin intended for persons living in Australia.
  • Drug - 14 Dec 2021
    Consumer Medicine Information (CMI) about Gold Cross Codeine Linctus intended for persons living in Australia.
  • Drug - 23 Sep 2021
    Consumer Medicine Information (CMI) about Syquet XR intended for persons living in Australia.
  • Drug - 5 Aug 2020
    Consumer Medicine Information (CMI) about Abstral sublingual tablets intended for persons living in Australia.
  • Supplier - 19 Jan 2023
    Scitegrity was founded in 2011 by ex-Pfizer, GSK and Roche chemists and data scientists with the goal of making compliance to chemical regulations are far more robust, accurate and automatic.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.